Quote of the Day
"The cost of consistently attempting to predict the next equity market drawdown – and often being wrong – will be pernicious and permanent."
(Joe Wiggins)
Strategy
- Stop dissing standard deviation as a risk measure. (morningstar.com)
- ETF is not a euphemism for good investment. (etf.com)
Finance
- Can Citi ($C) ever catch up to its peers? (wsj.com)
- Where did all the Chinese IPOs go? (nytimes.com)
- The Series A crunch is here. (tomtunguz.com)
Weight loss
- Novo Nordisk ($NVO) is building a new plant in North Carolina to manufacture weight loss drugs. (axios.com)
- Wegovy has been approved for sale in China. (semafor.com)
- The use of tirzepatide can apparently treat sleep apnea. (newatlas.com)
- Asking someone about weight loss these days is fraught. (wapo.st)
Economy
- The March Case-Shiller home prices indices showed a 6.3% year-over-year increase. (calculatedriskblog.com)
- How home prices will filter through to CPI. (bonddad.blogspot.com)
Earlier on Abnormal Returns
- Research links: training and testing. (abnormalreturns.com)
- What you missed in our Tuesday linkfest. (abnormalreturns.com)
- Adviser links: a sense of purpose. (abnormalreturns.com)
- Are you a financial adviser looking for some out-of-the-box thinking? Then check out our weekly e-mail newsletter. (newsletter.abnormalreturns.com)
